Mangoceuticals, inc. executes exclusive distribution agreement with propre energie for clinically proven dermytol®️ skincare treatment targeting hyperpigmentation

Dallas, tx & quebec, canada, feb. 03, 2025 (globe newswire) -- mangoceuticals, inc. (nasdaq: mgrx), a company focused on developing, marketing, and selling a variety of men's wellness products and services via a secure telemedicine platform, is pleased to announce that it has entered into an exclusive master distribution agreement with propre energie, inc., the developer of skincare brand dermytol®, a clinically proven treatment designed to improve skin tone and reduce hyperpigmentation.
MGRX Ratings Summary
MGRX Quant Ranking